This topic contains a solution. Click here to go to the answer

Author Question: When a person is unable to recognize a sense of loss and develops guilt feelings, what type of grief ... (Read 97 times)

jessicacav

  • Hero Member
  • *****
  • Posts: 558
When a person is unable to recognize a sense of loss and develops guilt feelings, what type of grief is the person experiencing?
 
  a. disenfranchised c. displaced
  b. delayed d. distorted

Question 2

When an individual continues to experience grief despite the fact that others feel the loss was insignificant, the grief is considered to be:
 
  a. chronic c. exaggerated
  b. delayed d. masked



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt95

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

A
Disenfranchised grief is not openly acknowledged, socially sanctioned, or publicly shared (i.e., a person is reluctant to recognize the sense of loss, feels guilty, or experiences social pressure to resume life activities).

Answer to Question 2

C
Chronic grief is associated with long-term coping with a loss; with delayed grief, the person does not readily identify the loss. A reaction that is considered to be extreme for the circumstance is considered to be exaggerated grief.




jessicacav

  • Member
  • Posts: 558
Reply 2 on: Jul 22, 2018
Great answer, keep it coming :)


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
Gracias!

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

For a complete list of videos, visit our video library